MET and hepatocellular carcinoma: EGFR inhibitors could decrease the phosphorylation level of MET that was activated endogenously or exogenously in HCC cell lines which were sensitive to EGFR inhibitors, but it did not work effectively in HCC cell lines with low phosphorylation of EGFR (Fig. 4J, K).